(E)-4-(4-((2-(3-hydroxybenzoyl)hydrazono)methyl)phenoxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide

ID: ALA4071945

PubChem CID: 137639583

Max Phase: Preclinical

Molecular Formula: C22H16N4O7S

Molecular Weight: 480.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N/N=C/c1ccc(Oc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)cc1)c1cccc(O)c1

Standard InChI:  InChI=1S/C22H16N4O7S/c27-17-6-4-5-16(13-17)20(28)24-23-14-15-9-11-18(12-10-15)32-21-22(26(29)33-25-21)34(30,31)19-7-2-1-3-8-19/h1-14,27H,(H,24,28)/b23-14+

Standard InChI Key:  NUCOZLIURDZISA-OEAKJJBVSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   36.6580  -15.2460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.4917  -14.2967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.2883  -14.5155    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   38.0738  -13.7178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.5311  -15.6504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5258  -16.4699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2324  -16.8845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9447  -16.4766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9460  -15.6539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2388  -15.2471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3655  -15.6557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4551  -16.4706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2583  -16.6416    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.6679  -15.9302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.1176  -15.3223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0734  -14.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6766  -14.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4574  -14.5634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6282  -13.7593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0162  -13.2072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2378  -13.4618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4848  -15.8458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.8116  -16.8785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1022  -16.4617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.3880  -16.8661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6785  -16.4534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9684  -16.8579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6874  -15.6321    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2623  -16.4418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5486  -16.8456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5434  -17.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2578  -18.0844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9686  -17.6742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8394  -16.4325    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  2  0
  4  3  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9  1  1  0
  1 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 15  3  1  0
  3 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 14 22  1  0
  6 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 27  1  0
 30 34  1  0
M  CHG  2  14   1  22  -1
M  END

Alternative Forms

  1. Parent:

    ALA4071945

    ---

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 480.46Molecular Weight (Monoisotopic): 480.0740AlogP: 2.40#Rotatable Bonds: 7
Polar Surface Area: 158.03Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.76CX Basic pKa: CX LogP: 2.57CX LogD: 2.55
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.28

References

1. Dutra LA, Guanaes JFO, Johmann N, Lopes Pires ME, Chin CM, Marcondes S, Dos Santos JL..  (2017)  Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.,  27  (11): [PMID:28400236] [10.1016/j.bmcl.2017.04.007]

Source